Physician

Stacey Lin Brown-Brocklehurst, MD

According to 2025 Medicare claims, Stacey Brown-Brocklehurst, MD (NPI: 1427233634) practices family practice in the Wheeling, WV-OH market, with the plurality of this provider's patient population coming from Belmont, OH. This provider's primary affiliated billing organization is WHEELING HOSPITAL INC (NPI: 1548923923; TIN: 55-0357057) and primary practice location at 43950-9119. Brown-Brocklehurst is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Brown-Brocklehurst's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 290 traditional Medicare patients, billed 1,278 HCPCS/CPT codes, and received $53,562 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,077 prescription claims across 728 beneficiaries totaling $491,345 in drug costs, led by Ozempic (Semaglutide). DME data shows 114 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $41,335 to $53,562. Similarly, Part D prescription costs have risen steadily, from $277,076 to $491,345. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $13,029 and ending at $15,876.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	282	1,073	$41,335
2016	214	664	$32,955
2017	348	898	$41,067
2018	379	947	$42,257
2019	360	1,227	$61,503
2020	322	923	$42,977
2021	1,443	4,013	$107,988
2022	1,445	3,830	$91,167
2023	288	833	$47,449
2024	290	1,278	$53,562

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	445	4,126	$277,076
2016	389	3,580	$271,647
2017	275	4,050	$275,269
2018	312	4,214	$320,160
2019	405	4,729	$376,574
2020	476	4,802	$370,139
2021	601	5,194	$414,873
2022	621	3,822	$350,918
2023	629	4,131	$414,697
2024	728	5,077	$491,345

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	207	$11,784
2016	N/R	170	$5,985
2017	12	150	$11,089
2018	16	162	$4,562
2019	14	167	$5,293
2020	16	144	$10,169
2021	N/R	97	$6,740
2022	N/R	42	$1,968
2023	N/R	90	$9,561
2024	N/R	114	$14,511

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	84	84	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	148	250	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	41	49	$35
77063	Screening 3d breast mammography	39	39	$21
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	40	44	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	110	4,281	$132,731
Trulicity	Dulaglutide	32	1,288	$42,506
Eliquis	Apixaban	32	1,995	$37,259
Xarelto	Rivaroxaban	34	1,676	$30,443
Jardiance	Empagliflozin	24	1,560	$30,363

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	17	$9,068
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	62	$4,951
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	24	$440
E0570	Nebulizer, with compressor	Y	N/R	11	$51

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Stacey Lin Brown-Brocklehurst, MD?

Tedicare shows public-source Medicare data for Stacey Lin Brown-Brocklehurst, MD (NPI 1427233634), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stacey Lin Brown-Brocklehurst, MD have ACO affiliation data?

Stacey Lin Brown-Brocklehurst, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Stacey Lin Brown-Brocklehurst, MD?

Stacey Lin Brown-Brocklehurst, MD is linked to WHEELING HOSPITAL INC (billing NPI 1548923923) in the available physician profile data.

Does Stacey Lin Brown-Brocklehurst, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.